Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

    Risultato della ricerca: Articlepeer review

    Fingerprint

    Entra nei temi di ricerca di 'Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.'. Insieme formano una fingerprint unica.

    Medicine & Life Sciences